The Great News – Lifestyle
Home
Sample Page
Author:
LeonaBio, Inc.
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
May 7, 2026
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
April 29, 2026
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
April 28, 2026